Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's rare heart disease drug succeeds in late-stage study
Pfizer's rare heart disease drug succeeds in late-stage study
Pfizer's rare heart disease drug succeeds in late-stage study
Submitted by
admin
on March 30, 2018 - 9:35am
Source:
Yahoo/Reuters
News Tags:
Pfizer
clinical trials
tafamidis
transthyretin cardiomyopathy
rare disease
Alnylam
Ionis Pharmaceuticals
Headline:
Pfizer's rare heart disease drug succeeds in late-stage study
Do Not Allow Advertisers to Use My Personal information
